Navigation Links
Penn team receives $20 million in federal funding to establish Tobacco Center of Regulatory Science
Date:9/24/2013

Philadelphia -- A $20 million federal grant will create the University of Pennsylvania Tobacco Center of Regulatory Science (Penn TCORS). A first-of-its-kind regulatory science research enterprise, the new center is designed to conduct studies to inform the regulation of tobacco products to protect public health. The new grant is supported by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) and will fund research from 2103 to 2018.

The new Penn TCORS, co-led by Penn Professors Robert Hornik and Caryn Lerman, includes faculty experts from the Annenberg School for Communication, the Perelman School of Medicine, and the Wharton School. The Penn TCORS is among 14 centers from across the nation which will receive a total of up to $53 million for tobacco-related research in fiscal year 2013. The Penn TCORS will have a thematic focus on tobacco-related messaging in the complex, 21st century communication environment, with projects that address multiple levels of effect, extending from neuroscience to health policy.

Despite decades of work to reduce its prevalence, tobacco use in the United States continues to be the leading cause of preventable death and disease.

"Public communication about tobacco products has been transformed by the digital marketing revolution and the rapid diffusion of emerging social media," said Robert Hornik, PhD, Wilbur Schramm Professor of Communication and Health Policy in the Annenberg School for Communication "As a result, tobacco product information and misinformation is readily available through mass media sources such as newspapers and TV, social media such as Twitter, user commentary on media, and the cigarette package itself. Such misinformation can mislead the public to underestimate the dangers or overestimate the benefits of various tobacco products, and threatens to undermine FDA's regulatory efforts."

The Penn TCORS will carry out several projects, including:

  • A comprehensive analysis of the nature and effects of both traditional and emerging media coverage of tobacco products on youth and young adults.
  • Experimental analyses of "belief echoes" -- lingering public attitudes based on misinformation about tobacco products -- and will examine novel, theory-based corrective interventions.
  • Experimental analysis of the effects of cigarette packaging formats on smoking behavior as well as downstream biological effects.
  • Establishing the Tobacco Fact Check Core, a tobacco specific version of APPC's award-winning FactCheck.org and FlackCheck.org, each of which uncovers fact from fiction and/or "spin" in political messages.

In addition, a new training program will provide opportunities for doctoral students and postdoctoral fellows to strengthen their research capacity in tobacco communication and regulatory science in an intensive, rigorous, multi-disciplinary environment.

"Despite massive efforts to eradicate tobacco addiction -- and some significant successes -- tobacco dependence continues to be a major public health problem," said Caryn Lerman, PhD, Mary W. Calkins Professor in the Department of Psychiatry at the Perelman School of Medicine and the Annenberg School for Communication, and Deputy Director of Penn's Abramson Cancer Center. "By marshalling the tremendous resources we have at Penn Medicine and Annenberg, we're aiming to uncover new ways of countering the insidious effects of advertising and misinformation that induce people, especially the young, to adopt this lethal habit."


'/>"/>

Contact: Holly Auer
holly.auer@uphs.upenn.edu
215-200-2313
University of Pennsylvania School of Medicine
Source:Eurekalert

Related medicine news :

1. Loyola Cancer Center receives Outstanding Achievement Award
2. MU receives national award for using mind-body approach to improve health
3. Neuropsychologist receives University of Houstons highest faculty honor
4. Boston researcher, surgical oncologist receives national award
5. LA BioMed receives Grand Challenges Explorations grant
6. Lawson researcher receives 1 of first-ever Pfizer Psychiatry Research Awards
7. Dr. Arthur Slutsky, vice-president of research at St. Michaels, receives lifetime award
8. UC San Diego Superfund Research Program receives $15 million grant renewal
9. Markey receives $6.25 million to study deadly blood and bone marrow disease
10. Feola, at University of Kentucky, receives NIH grant to study cystic fibrosis
11. UC Santa Barbaras Kavli Institute receives 2 grants to explore interface of physics and biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Surgical Procedure Volumes: Global Analysis (United States, ... Australia, Canada)" report to their offering. ... an essential tool for healthcare business planners, provides surgical ... looks at surgery trends with an in-depth analysis of ...
Breaking Medicine Technology: